Industry
Avera Pharmaceuticals
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
50.0%-37% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
Failure Rate
50.0%
2 terminated/withdrawn out of 4 trials
Success Rate
50.0%
-36.6% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Phase 1
2(50.0%)
Phase 2
2(50.0%)
4Total
Phase 1(2)
Phase 2(2)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT00294346Phase 2Completed
Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder
Role: lead
NCT00316550Phase 1Terminated
Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome
Role: lead
NCT00335660Phase 2Terminated
Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity
Role: lead
NCT00235976Phase 1Completed
The Efficacy and Safety of Gantacurium Chloride for Injection in Tracheal Intubation in Healthy Adult Patients Undergoing Surgery Under General Anesthesia
Role: lead
All 4 trials loaded